- Argenx deepens immuno expertise with $2.2B Forte Biosciences buyThe star of the takeover is Forte Biosciences' investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.BioSpace · 1d ago↗ source
- [Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical ServicesThis podcast explores how clinical trial supplies move from early planning to global delivery, ensuring investigational medicines reach patients safely and on time.BioPharma Dive · 1d ago↗ source
- [Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in FocusThis podcast explores how leading Alzheimer’s experts are working to bridge the gap between clinical trial design and frontline care.BioPharma Dive